| Literature DB >> 33975608 |
Vira Chea1, Valerie Pleiner1, Viviane Schweizer1, Benjamin Herzog2, Beata Bode1, Marianne Tinguely3.
Abstract
BACKGROUND: Effective workflow management in a diagnostic pathology laboratory is critical to achieve rapid turnover while maintaining high quality. Fluorescence in situ hybridization analysis (FISH) is the preferred technique for detecting single chromosomal aberrations in diagnostic surgical pathology.Entities:
Keywords: Digital pathology; FISH; Image analysis; Lymphoma; Sarcoma
Year: 2021 PMID: 33975608 PMCID: PMC8114497 DOI: 10.1186/s13000-021-01103-5
Source DB: PubMed Journal: Diagn Pathol ISSN: 1746-1596 Impact factor: 2.644
Summaries of FISH cut-off and scanning profile
| A) Break apart probes with comparison of cut off values from the literature. ° dual colour dual fusion | |||
| 4 | 10 | ||
| 4 | 8 | ||
| 4 | 1.3 | ||
| 5 | 5 ° | ||
| 7 | 10 | ||
| 3 | NA | ||
| 5 | 9 | ||
| 3 | 20 | ||
| B) Comparison of scanning time, file size and FOV (fields of fiew) scanned with the two profiles in 42 diagnostic cases | |||
| | 1 | 3 | 1 |
| | 1620 | 1620 | 72 |
| | 87 | 159 | 15 |
| | 34 | 57 | 11 |
| | 17 | 17 | 30 |
| | 7620 | 7620 | 940 |
| | 794 | 1129 | 458 |
| | 468 | 607 | 328 |
| | 105 | 105 | 120 |
| | 58830 | 58830 | 10620 |
| | 3840 | 5971 | 1708 |
| | 1713 | 2311 | 1114 |
Fig. 1Comparison of a case scanned by the low profile (a) versus high profile (b) using a C-MYC bap probe. The high profile results in a better signal to noise ratio without fading. The settings applied are shown in (c) resulting in different storage sizes
Fig. 2Clinical samples of routine diagnostic cases with the corresponding HE: (a) Parallel viewing of a primary cutaneous marginal zone lymphoma: (i) BCL2 BAP probe, (ii) HE, (iii) CD20 (iiii) Bcl2; (b, c) Lipoma without MDM2 amplification; (d, e) Metastases of a cholangiocellular carcinoma showing the pre-analytical tissue selection area annotated on the CaseViewer and the corresponding MDM2 amplification; (f, g) “double hit” lymphoma with a C-MYC break in the annotated tumour cells and a break in the BCL-6 gene (h)